Disclaimer: This product is not intended to diagnose, treat, cure, or prevent any disease
Before starting Rybelsus , contact your GP if you have a history of: Pancreatitis (inflammation of the pancreas) GLP-1 receptor agonists have been associated with pancreatitis in rare cases [1] [5] Severe gastrointestinal disease , including gastroparesis or inflammatory bowel disease Diabetic retinopathy rapid improvements in glucose control may temporarily worsen this condition [1] [2] Thyroid disease while the UK product information notes rodent C-cell tumours with uncertain human relevance, discuss any thyroid conditions with your doctor [1] [4] During treatment , seek medical advice if you experience: Severe, persistent abdominal pain that may radiate to the back if pancreatitis is suspected, stop taking Rybelsus immediately and seek urgent medical assessment
Regulatory authorities require ongoing pharmacovigilance, including periodic safety update reports from the manufacturer
Bu nedenle ila seimi mutlaka hekim deerlendirmesiyle yaplmaldr
Zepbound contains tirzepatide, which was approved for weight loss in November 2023